Cullinan Oncology
Income Statement
Last updated:
Income statement is a financial statement that shows how profitable a business was over a given reporting period presenting its revenue, expenses or net income. The net income dropped to -$153,162,000 over the previous period. Total operating expenses were $191,089,000.
Profit Margin
| 2018 | 0 | -14.18M | |
|---|---|---|---|
| 2019 | 0 | -20.03M | |
| 2020 | 0 | -50.84M | |
| 2021 | 18.94M | -65.04M | -343.35% |
| 2022 | 0 | 111.21M | |
| 2023 | 0 | -153.16M |
CGEM Income Statement (2018 – 2023)
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | |
|---|---|---|---|---|---|---|
Revenue | ||||||
Revenue | 0 | 0 | 18.94M | 0 | 0 | 0 |
Cost of revenue | 310K | 93K | 53K | 62K | 70K | 0 |
Gross profit | -310K | -93K | 18.89M | -62K | -70K | 0 |
Operating exp. | ||||||
Research and development | 148.15M | 91.94M | 57.75M | 43.21M | 16.78M | 9.58M |
Selling and marketing | 0 | 0 | 0 | 0 | 0 | 0 |
Total operating expenses | 191.08M | 132.13M | 86.89M | 60.33M | 22.27M | 14.58M |
Operating income | -191.08M | 144.64M | -67.95M | -60.33M | -22.27M | -14.58M |
Other income (expenses), net | 21.86M | 6.66M | 469K | 877K | 616K | 397K |
Income before tax | -169.22M | 151.31M | -67.48M | -59.45M | -21.65M | -14.18M |
Income tax expense | -14.12M | 42.12M | -2.44M | -8.60M | -1.61M | 397K |
Net income | -153.16M | 111.21M | -65.04M | -50.84M | -20.03M | -14.18M |
Earnings per share | ||||||
Basic EPS | -3.69 | 2.46 | -1.47 | -1.17 | -0.46 | -1.24 |
Diluted EPS | -3.69 | 2.38 | -1.47 | -1.17 | -0.46 | -1.24 |
| Data source | Data source | Data source | Data source |